Author:
A. Shankarnarayan Shamanth,D. Guthrie Joshua,A. Charlebois Daniel
Abstract
Machine learning is a subfield of artificial intelligence which combines sophisticated algorithms and data to develop predictive models with minimal human interference. This chapter focuses on research that trains machine learning models to study antimicrobial resistance and to discover antimicrobial drugs. An emphasis is placed on applying machine learning models to detect drug resistance among bacterial and fungal pathogens. The role of machine learning in antibacterial and antifungal drug discovery and design is explored. Finally, the challenges and prospects of applying machine learning to advance basic research on and treatment of antimicrobial resistance are discussed. Overall, machine learning promises to advance antimicrobial resistance research and to facilitate the development of antibacterial and antifungal drugs.
Reference190 articles.
1. Fleming A. Sir Alexander Fleming—Nobel Lecture: Penicillin. Nobel Lect; 1945
2. WHO. Antimicrobial Resistance [Internet]. 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
3. MacGowan AP. Clinical implications of antimicrobial resistance for therapy. The Journal of Antimicrobial Chemotherapy. 2008;62(SUPPL. 2):105-114
4. O’Neill J. Review on Antimicrobial Resistance: Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. London: Wellcome Trust; 2016. p. 80
5. Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet. 2022;6736(21):629-655
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献